Medical Tourism Safety Guide: How to Vet a Regenerative Medicine Clinic Abroad

The rapid growth of regenerative medicine in Latin America and other international destinations has created a wide spectrum of options — from exceptional clinics operating at the highest medical standards to operators with no meaningful clinical oversight. For patients considering treatment abroad, knowing how to distinguish between them is not optional. It is the most important step in the entire process.

We wrote this guide to help patients ask the right questions — of any clinic, including ours. Transparency on these points is not just an ethical standard; it's a practical signal of operational quality.

Start with Accreditation

The first question to ask any clinic is: what are your accreditations, and can you provide documentation? Meaningful accreditations include:

• JCI (Joint Commission International): The global standard for hospital accreditation, equivalent to US Joint Commission certification. JCI-accredited facilities in Mexico, Costa Rica, and Colombia meet the same process standards as top US hospitals.
• National health ministry certification: In Mexico (COFEPRIS), Colombia (INVIMA), and Costa Rica (CCSS/Ministerio de Salud), certification to operate advanced therapy medicinal product protocols is legally required.
• ISO-certified cell processing: The laboratory where cells are processed should operate under ISO 9001/13485 or GMP (Good Manufacturing Practice) standards. Ask for the certificate.

If a clinic cannot provide documentation for these certifications, that is a significant red flag. Legitimate facilities are proud to share this information.

Verify the Physician's Credentials

The physician administering your treatment should hold active board certification in a relevant specialty — not a certificate from a "regenerative medicine" continuing education course. Ask specifically:

• What medical degree, from which institution?
• What specialty board certification?
• How many patients have they personally treated with this specific protocol?
• Are they listed on the national medical registry (Cédula Profesional in Mexico; Registro Médico in Colombia)?

Credentials should be verifiable. In Mexico, all licensed physicians are listed in the Cédula Profesional database (cedulaprofesional.sep.gob.mx). Request the physician's cedula number and verify it.

Biological Traceability: Follow the Cells

This is the area where the most consequential differences between legitimate and questionable operations emerge. Every cell preparation administered to a patient should have a documented chain of custody from donor to patient. Ask for:

• Donor screening documentation: Was the donor tested for HIV, HBV, HCV, CMV, syphilis, and other communicable diseases according to AABB or equivalent standards?
• Processing facility certification: GMP or ISO certificate for the laboratory — not just the clinic
• Cell viability and sterility testing: Each lot should have a certificate of analysis showing viability (≥80% for clinical use), sterility (negative for bacteria/fungi/mycoplasma), and identity confirmation
• Cell count documentation: How many cells are in your dose? This number matters clinically — a reputable provider specifies it
• Storage and transport chain: How were cells transported and stored? Temperature excursions can significantly reduce viability

The 11 Questions Every Patient Must Ask

Red Flags: When to Walk Away

• Guaranteed outcomes or cure claims for serious conditions
• Inability or refusal to provide a Certificate of Analysis for cell preparations
• Physician credentials that cannot be independently verified
• Prices dramatically lower than comparable legitimate clinics (cells cost what they cost to produce properly)
• No structured follow-up protocol after treatment
• Pressure to decide quickly or limited-time pricing
• No published outcomes data or patient references
• Facility that cannot name the laboratory where cells are processed

Which Renuvia pathway fits this topic?